Implantation of a transcutaneous, bone-anchored, piezoelectric bone conduction hearing aid on the squama temporalis

Bone-anchored hearing implants, such as the Osia® system (Cochlear Deutschland GmbH, Hanover, Germany), are used to rehabilitate conductive hearing loss, mixed hearing loss, and single-sided deafness. The surgical technique presented anchors the OSI300 supraauricularly and subperiosteally over the squama temporalis, thereby avoiding the creation of an implant bed in the mastoid and reducing cosmetic contour...

Continue reading at PubMed →

Evidence on squama temporalis implantation of Osia® is emerging; audiologists involved in pre-surgical counselling should note this placement option, but await larger controlled studies before routine expectation-setting changes.

As transcutaneous bone-anchored devices gain adoption, data on alternative implant sites like the squama temporalis inform surgical planning and expand candidacy discussions for bone conduction rehabilitation.

1. 01Study evaluates the Osia® piezoelectric bone conduction system implanted on the squama temporalis.
2. 02Target population includes conductive, mixed, and single-sided deafness (SSD) patients.
3. 03Published in HNO, a peer-reviewed German-language otolaryngology journal.
4. 04Transcutaneous design avoids external abutment, potentially reducing infection risk vs. percutaneous devices.
5. 05Evidence base and sample size details are not yet fully extractable without full-text access.

PMID

42825948

DOI

10.1007/s00106-026-01800-x.

Journal

HNO

Publication type

research_article

Evidence level

4

Population

Patients with conductive, mixed, or single-sided deafness undergoing bone-anchored hearing device implantation

Intervention

Transcutaneous bone-anchored piezoelectric bone conduction hearing system (Osia®) implanted on the squama temporalis